Literature DB >> 27694175

Bombesin-Targeted PET of Prostate Cancer.

Rosalba Mansi1, Ryogo Minamimoto2, Helmut Mäcke1, Andrei H Iagaru3.   

Abstract

Imaging plays an important role in prostate cancer (PC), including accurate evaluation of the extent of disease, assessment of sites of recurrent disease, and monitoring of response to treatment. Molecular imaging techniques are among the novel developments related to the imaging of PC, and various SPECT and PET radiopharmaceuticals are now available in clinical trials or commercially. Here we describe the preclinical and clinical use of gastrin-releasing peptide receptors as targets for the imaging of PC, with a focus on the development of PET tracers for the imaging of gastrin-releasing peptide receptor-positive tumors.
© 2016 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  PET; bombesin; cancer; prostate

Mesh：

Substances：

Year:  2016        PMID： 27694175     DOI： 10.2967/jnumed.115.170977

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  8 in total

1.  PET Using a GRPR Antagonist 68Ga-RM26 in Healthy Volunteers and Prostate Cancer Patients.

Authors:  Jingjing Zhang; Gang Niu; Xinrong Fan; Lixin Lang; Guozhu Hou; Libo Chen; Huanwen Wu; Zhaohui Zhu; Fang Li; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2017-11-09       Impact factor: 10.057

2.  Design and Investigation of a [18F]-Labeled Benzamide Derivative as a High Affinity Dual Sigma Receptor Subtype Radioligand for Prostate Tumor Imaging.

Authors:  Dongzhi Yang; Anthony Comeau; Wayne D Bowen; Robert H Mach; Brian D Ross; Hao Hong; Marcian E Van Dort
Journal:  Mol Pharm       Date:  2017-02-14       Impact factor: 4.939

Review 3.  Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.

Authors:  David G Calatayud; Sotia Neophytou; Eleni Nicodemou; S Giuseppe Giuffrida; Haobo Ge; Sofia I Pascu
Journal:  Front Chem       Date:  2022-04-12       Impact factor: 5.545

Review 4.  A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling?

Authors:  Cyril Fersing; Ahlem Bouhlel; Christophe Cantelli; Philippe Garrigue; Vincent Lisowski; Benjamin Guillet
Journal:  Molecules       Date:  2019-08-07       Impact factor: 4.411

5.  Bombesin receptor-targeted liposomes for enhanced delivery to lung cancer cells.

Authors:  Mohammad J Akbar; Pâmela C Lukasewicz Ferreira; Melania Giorgetti; Leanne Stokes; Christopher J Morris
Journal:  Beilstein J Nanotechnol       Date:  2019-12-19       Impact factor: 3.649

6.  Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist.

Authors:  Michael Hofstetter; Euy Sung Moon; Fabio D'Angelo; Lucien Geissbühler; Ian Alberts; Ali Afshar-Oromieh; Frank Rösch; Axel Rominger; Eleni Gourni
Journal:  EJNMMI Radiopharm Chem       Date:  2020-11-30

7.  Structural Investigations, Cellular Imaging, and Radiolabeling of Neutral, Polycationic, and Polyanionic Functional Metalloporphyrin Conjugates.

Authors:  Valeria Ciaffaglione; Philip A Waghorn; Rüdiger M Exner; Fernando Cortezon-Tamarit; Samuel P Godfrey; Sophia Sarpaki; Helena Quilter; Ruggero Dondi; Haobo Ge; Gabriele Kociok-Kohn; Stanley W Botchway; Ian M Eggleston; Jonathan R Dilworth; Sofia I Pascu
Journal:  Bioconjug Chem       Date:  2021-02-01       Impact factor: 4.774

Review 8.  Positron emission tomography (PET) in primary prostate cancer staging and risk assessment.

Authors:  Sandra Bednarova; Maria L Lindenberg; Maria Vinsensia; Chiara Zuiani; Peter L Choyke; Baris Turkbey
Journal:  Transl Androl Urol       Date:  2017-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.